1120PDBuparlisib (BKM120) in refractory head and neck...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

1120PDBuparlisib (BKM120) in refractory head and neck squamous cell carcinoma harbouring or not a PI3KCA mutation: A phase II multicenter trial

Fayette, J, Digue, L, Ségura-Ferlay, C, Treilleux, I, Wang, Q, Lefebvre, G, Daste, A, Even, C, Couchon Thaunat, S, Guyennon, A, Peyrade, F, Cupissol, D, You, B, Le Tourneau, C, Jaouen, L, Grinand, E,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz252.012
Date:
October, 2019
File:
PDF, 78 KB
2019
Conversion to is in progress
Conversion to is failed